A novel pharmaceutical compound containing abacavir sulfate and methods of making and using same

Details for Australian Patent Application No. 2001298033 (hide)

Owner New River Pharmaceuticals Inc.

Inventors Picariello, Thomas

Agent FB Rice

Pub. Number AU-B-2001298033

PCT Number PCT/US01/43089

PCT Pub. Number WO2003/034980

Priority 60/247,561 14.11.00 US; 60/247,616 14.11.00 US; 60/247,926 14.11.00 US; 60247,833 14.11.00 US; 60/247,559 14.11.00 US; 60/247,607 14.11.00 US; 60/247,635 14.11.00 US; 60/247,633 14.11.00 US; 60/247,927 14.11.00 US; 60/247,628 14.11.00 US; 60/247,606 14.11.00 US; 60/247,634 14.11.00 US; 60/247,798 14.11.00 US; 60/247,804 14.11.00 US; 60/247,617 14.11.00 US; 60/247,807 14.11.00 US; 60/247,595 14.11.00 US; 60/247,629 14.11.00 US; 60/247,630 14.11.00 US; 60/247,594 14.11.00 US; 60/247,702 14.11.00 US; 60/247,930 14.11.00 US; 60/2

Filing date 14 November 2001

Wipo publication date 6 May 2003

Acceptance publication date 9 August 2007

International Classifications

A61K 9/22 (2006.01) Medicinal preparations characterised by special physical form - Sustained or differential release type

A61K 9/52 (2006.01) Medicinal preparations characterised by special physical form - Sustained or differential release type

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/52 (2006.01)

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

Event Publications

3 April 2003 Complete Application Filed

  Priority application(s): 60/247,561 14.11.00 US; 60/247,616 14.11.00 US; 60/247,926 14.11.00 US; 60247,833 14.11.00 US; 60/247,559 14.11.00 US; 60/247,607 14.11.00 US; 60/247,635 14.11.00 US; 60/247,633 14.11.00 US; 60/247,927 14.11.00 US; 60/247,628 14.11.00 US; 60/247,606 14.11.00 US; 60/247,634 14.11.00 US; 60/247,798 14.11.00 US; 60/247,804 14.11.00 US; 60/247,617 14.11.00 US; 60/247,807 14.11.00 US; 60/247,595 14.11.00 US; 60/247,629 14.11.00 US; 60/247,630 14.11.00 US; 60/247,594 14.11.00 US; 60/247,702 14.11.00 US; 60/247,930 14.11.00 US; 60/2

3 July 2003 Application Open to Public Inspection

  Published as AU-B-2001298033

9 August 2007 Application Accepted

  Published as AU-B-2001298033

6 December 2007 Standard Patent Sealed

17 January 2008 Assignment Registered

  New River Pharmaceuticals Inc. The patent has been assigned to Shire LLC

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001298034-Stabilized energetic water in oil emulsion composition

2001298032-METHOD AND APPARATUS FOR PHYSICAL CHARACTERISTICS DISCRIMINATION OF OBJECTS USING A LIMITED VIEW THREE DIMENSIONAL RECONSTRUCTION